Publication | Closed Access
Vasopressor effect of lysophosphatidic acid on spontaneously hypertensive rats and Wistar Kyoto rats.
27
Citations
0
References
1995
Year
HypertensionVasopressor EffectPharmacotherapyWistar Kyoto RatsBlood PressureIntravenous InjectionLysophosphatidic AcidAtherosclerosisEndocrine HypertensionSodium HomeostasisAntihypertensive TherapyVascular PharmacologyVascular BiologyMean Blood PressureEndocrinologyPharmacologyCardiovascular DiseasePhysiologyMedicine
Intravenous injection of lysophosphatidic acid (LPA, 1-acyl-sn-glycerol-3-phosphate) into conscious, spontaneously hypertensive rats (SHR) promptly elicited hypertension in a dose-dependent manner, its effect being significantly higher than in conscious, age-matched Wistar Kyoto strain rats (WKY). There was, however, no difference between the potencies of LPA in raising the mean blood pressure of SHR and WKY anesthetized with pentobarbital. The releases of norepinephrine, angiotensin II, prostaglandin and leukotriene were found not to be involved in the vasopressor effect of LPA in SHR, although thromboxane seemed to be slightly related to the action of LPA.